Exposure to chemicals and metals and risk of amyotrophic lateral sclerosis: A systematic review

References

• Rowland LP, Shneider NA. Amyotrophic lateral sclerosis. N Engl J Med. 2001; 344: 1688–1700
   PubMed Web of Science ®Google Scholar
• Mitchell JD, Borasio GD. Amyotrophic lateral sclerosis. Lancet. 2007; 369: 2031–41
   PubMed Web of Science ®Google Scholar
• Simpson CL, Al-Chalabi A. Amyotrophic lateral sclerosis as a complex genetic disease. Biochim Biophys Acta. 2006; 1762: 973–85
   PubMed Web of Science ®Google Scholar
• Shaw CE, Al-Chalabi A, Leigh N. Progress in the pathogenesis of amyotrophic lateral sclerosis. Curr Neurol Neurosci Rep. 2001; 1: 69–76
   PubMedGoogle Scholar
• Slowik A, Tomik B, Wolkow PP, Partyka D, Turaj W, Malecki MT, et al. Paraoxonase gene polymorphisms and sporadic ALS. Neurology. 2006; 67: 766–70
   PubMed Web of Science ®Google Scholar
• Saeed M, Siddique N, Hung WY, Usacheva E, Liu E, Sufit RL, et al. Paraoxonase cluster polymorphisms are associated with sporadic ALS. Neurology. 2006; 67: 771–6
   PubMed Web of Science ®Google Scholar
• Cronin S, Greenway MJ, Prehn JH, Hardiman O. Paraoxonase promoter and intronic variants modify risk of sporadic amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2007; 78: 984–6
   PubMed Web of Science ®Google Scholar
• Haley RW. Gulf war syndrome: narrowing the possibilities. Lancet Neurol. 2003; 2: 272–3
   PubMed Web of Science ®Google Scholar
• Armon C. An evidence-based medicine approach to the evaluation of the role of exogenous risk factors in sporadic amyotrophic lateral sclerosis. Neuroepidemiology. 2003; 22: 217–28
   PubMed Web of Science ®Google Scholar
• Brown RC, Lockwood AH, Sonawane BR. Neurodegenerative diseases: an overview of environmental risk factors. Environ Health Perspect. 2005; 113: 1250–6
   PubMed Web of Science ®Google Scholar
• Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000; 283: 2008–12
   PubMed Web of Science ®Google Scholar
• McGuire V, Longstreth WT, Jr, Nelson LM, Koepsell TD, Checkoway H, Morgan MS, et al. Occupational exposures and amyotrophic lateral sclerosis. A population-based case-control study. Am J Epidemiol. 1997; 145: 1076–88
   PubMed Web of Science ®Google Scholar
• Park RM, Schulte PA, Bowman JD, Walker JT, Bondy SC, Yost MG, et al. Potential occupational risks for neurodegenerative diseases. Am J Ind Med. 2005; 48: 63–77
   PubMed Web of Science ®Google Scholar
• Vinceti M, Nacci G, Rocchi E, Cassinadri T, Vivoli R, Marchesi C, et al. Mortality in a population with long-term exposure to inorganic selenium via drinking water. J Clin Epidemiol. 2000; 53: 1062–8
   PubMed Web of Science ®Google Scholar
• Gait R, Maginnis C, Lewis S, Pickering N, Antoniak M, Hubbard R, et al. Occupational exposure to metals and solvents and the risk of motor neuron disease: a case-control study. Neuroepidemiology. 2003; 22: 353–6
   PubMed Web of Science ®Google Scholar
• Steenland K, Hein MJ, Cassinelli II RT, Prince MM, Nilsen NB, Whelan EA, et al. Polychlorinated biphenyls and neurodegenerative disease mortality in an occupational cohort. Epidemiology. 2006; 17: 8–13
   PubMed Web of Science ®Google Scholar
• Welp E, Kogevinas M, Andersen A, Bellander T, Biocca M, Coggon D, et al. Exposure to styrene and mortality from nervous system diseases and mental disorders. Am J Epidemiol. 1996; 144: 623–33
   PubMed Web of Science ®Google Scholar
• Lewis RJ, Schnatter AR, Katz AM, Thompson FS, Murray N, Jorgensen G, et al. Updated mortality among diverse operating segments of a petroleum company. Occup Environ Med. 2000; 57: 595–604
   PubMed Web of Science ®Google Scholar
• Chancellor AM, Slattery JM, Fraser H, Warlow CP. Risk factors for motor neuron disease: a case-control study based on patients from the Scottish Motor Neuron Disease Register. J Neurol Neurosurg Psychiatry. 1993; 56: 1200–6
   PubMed Web of Science ®Google Scholar
• Longnecker MP, Kamel F, Umbach DM, Munsat TL, Shefner JM, Lansdell LW, et al. Dietary intake of calcium, magnesium and antioxidants in relation to risk of amyotrophic lateral sclerosis. Neuroepidemiology. 2000; 19: 210–6
   PubMed Web of Science ®Google Scholar
• Haley RW. Excess incidence of ALS in young Gulf War veterans. Neurology. 2003; 61: 750–6
   PubMed Web of Science ®Google Scholar
• Horner RD, Kamins KG, Feussner JR, Grambow SC, Hoff-Lindquist J, Harati Y, et al. Occurrence of amyotrophic lateral sclerosis among Gulf War veterans. Neurology. 2003; 61: 742–9
   PubMed Web of Science ®Google Scholar
• Al-Chalabi A, Leigh PN. Trouble on the pitch: are professional football players at increased risk of developing amyotrophic lateral sclerosis?. Brain. 2005; 128: 451–3
   PubMed Web of Science ®Google Scholar
• Jenner P, Olanow CW. Understanding cell death in Parkinson's disease. Ann Neurol. 1998; 44: S72–84
   PubMed Web of Science ®Google Scholar
• Beal MF. Mitochondria take centre stage in ageing and neurodegeneration. Ann Neurol. 2005; 58: 495–505
   PubMed Web of Science ®Google Scholar
• Gorell JM, Johnson CC, Rybicki BA, Peterson EL, Richardson RJ. The risk of Parkinson's disease withx exposure to pesticides, farming, well water, and rural living. Neurology. 1998; 50: 1346–50
   PubMed Web of Science ®Google Scholar
• Strickland D, Smith SA, Dolliff G, Goldman L, Roelofs RI. Amyotrophic lateral sclerosis and occupational history: a pilot case-control study. Arch Neurol. 1996; 53: 730–3
   PubMedGoogle Scholar
• Beghi E. 127th ENMC International Workshop: implementation of a European registry of ALS. Naarden, The Netherlands, 8–10 October 2004. Neuromuscul Disord. 2006; 16: 46–53
   PubMedGoogle Scholar
• Chang, T.M.S. 2007. Monograph on Artificial Cells: Biotechnology, Nanotechnology, Blood Substitutes, Regenerative Medicine, Bioencapsulation, Cell/Stem Cell Therapy. World Science Publishers, Singapore.
   Google Scholar